Skip to main content
2023 Guide to Patient Support Services

Seagen

2023 PSS Guide

Seagen Secure Support Services

Seagen offers the Seagen Secure patient assistance program to help patients while taking a Seagen oncology medication (Table).

Seagen Secure

This program offers a comprehensive suite of programs, including the Commercial Out-of-Pocket Assistance Program, the Patient Assistance Program, and the Quick Start Program, as well as access to Oncology Access Advocates.

Commercial Out-of-Pocket Assistance Program

Eligible patients with commercial prescription insurance who are taking Tukysa may pay as little as $5 per prescription fill. Patients may be eligible if they:

  • Have commercial insurance
  • Have a prescription for Tukysa for an FDA-approved indication, and/or are being treated with capecitabine for an FDA-approved indication in combination with Tukysa
  • Do not participate in any federal, state, or other government health insurance program including, but not limited to, Medicare, including, Part D plans, Medicaid, Veterans Administration health coverage, TRICARE, or other Department of Defense health coverage, or the Puerto Rico Government Insurance Plan
  • Are a resident of the United States or Puerto Rico (for capecitabine only, this offer is not valid in Massachusetts or California)
  • Are receiving treatment from a physician in the United States, and product must be dispensed at participating eligible pharmacies in the United States, Puerto Rico, or US territories.

For patients taking Adcetris or Tivdak, call 855-473-2873 for more information about available out-of-pocket assistance.

Patient Assistance Program

For eligible uninsured and underinsured patients, the Patient Assistance Program provides the product for up to 1 year at no cost to patients who meet program eligibility requirements. Oncology Access Advocates can assess patient eligibility for this program.

Quick Start Program

The Quick Start Program provides a 15-day supply of Tukysa at no cost to patients who experience an insurance-related access delay.

Oncology Access Advocates

Once enrolled in Seagen Secure, patients will be assigned a dedicated Oncology Access Advocate who can assist with any coverage or financial issues.

To learn more or to enroll your patient in Seagen Secure, call 855-473-2873 or visit SeagenSecure.com.

TABLE Seagen Oncology Drugs

Drugs
Indications
Patient support programs

Drug
Adcetris (brentuximab vedotin)
Indications
Patient support programs

Drug
Tivdak (tisotumab vedotin-tftv) for injection
Indications
Treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
Patient support programs

Drug
Tukysa (tucatinib) tablets
Indications
Treatment, in combination with trastuzumab and capecitabine, of adults with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received ≥1 HER2-targeted regimens in the metastatic setting
Patient support programs

Adcetris (brentuximab vedotin) Indications

Untreated stage III or IV classical Hodgkin lymphoma, in combination with doxorubicin, vinblastine, and dacarbazine; previously untreated high-risk classical Hodgkin lymphoma in pediatric patients 2 years and older, in combination with doxorubicin, vincristine, etoposide, prednisone, and cyclophosphamide; classical Hodgkin lymphoma ­at high risk for relapse or progression after autologous hematopoietic stem-cell transplant (HSCT) consolidation; classical Hodgkin lymphoma, after failure of autologous HSCT, or after ≥2 multiagent chemotherapy regimens if ineligible for transplant; untreated systemic anaplastic large-cell lymphoma or other CD30-expressing peripheral T-cell lymphoma in combination with chemotherapy; systemic anaplastic large-cell lymphoma after failure of ≥1 multiagent chemotherapy regimens; primary cutaneous anaplastic large-cell lymphoma, or CD30-expressing mycosis fungoides after systemic therapy

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"
Comments
(Optional)